Catalyst Pharmaceuticals CPRX reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Catalyst Pharmaceuticals beat estimated earnings by 64.71%, reporting an EPS of $0.28 versus an estimate of $0.17.
Revenue was up $16.75 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 6.06% drop in the share price the next day.
Here's a look at Catalyst Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 0.14 | 0.12 | 0.1 | 0.09 |
EPS Actual | 0.12 | 0.09 | 0.1 | 0.11 |
Revenue Estimate | 42.75M | 38.19M | 34.59M | 31.51M |
Revenue Actual | 43.09M | 38.31M | 35.95M | 36.37M |
To track all earnings releases for Catalyst Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.